https://www.selleckchem.com/pr....oducts/omaveloxolone
Their best responses were as follows 1 complete response, 3 partial responses, 7 stable diseases, and 11 progressive diseases. Additionally, the treated patients were divided on the basis of matching scores (≥ 50% vs. 50%). The patients were divided into high and low groups. The high group had a higher disease control rate (DCR) of 75% compared with 20% in the low group (P = 0.01. The results indicate that liquid biopsy is useful for identifying actionable mutations associated with the clinical response of selected
Like
Comment
Share
